Bridgewater Associates’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Bridgewater Associates's EXEL Position: Q2 2026 in Review
Bridgewater Associates reduced its Exelixis (EXEL) stake by 17% in Q2 2026, selling an estimated $3.9M and leaving 400,859 shares worth $21.8M. The position accounts for 0.09% of the portfolio, ranked #189.
Bridgewater Associates first reported a position in EXEL in Q2 2021 and has held it in 10 quarters since. The position peaked at $40.6M in Q4 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Bridgewater Associates held 400,859 shares of Exelixis worth $21.8M as of Q2 2026.
- Bridgewater Associates sold 80,137 Exelixis shares in Q2 2026, an estimated $3.9M.
- Exelixis made up 0.09% of Bridgewater Associates's portfolio in Q2 2026, its #189 holding.
- Bridgewater Associates first reported a position in Exelixis in Q2 2021 and has held it in 10 quarters since.
- Bridgewater Associates's Exelixis position peaked at $40.6M in Q4 2025.
- 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.